Pancreatic Cancer Research

ResearcherHospital Universitari i Politècnic La FeActive in the last 2 years

Robert Díaz Beveridge

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0003-3719-7014; OpenAlex author ID A5004062459, A5137139509. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. Real-world outcomes of FOLFIRINOX versus gemcitabine plus nab-paclitaxel and prognostic factors in advanced pancreatic cancer: a retrospective cohort study. Last author DOI 10.1177/17588359261456797↗
  2. Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer. Co-author DOI 10.1038/bjc.2016.271↗
  3. Management of advanced pancreatic cancer with gemcitabine plus erlotinib: efficacy and safety results in clinical practice. Co-author DOI 10.6092/1590-8577/1570↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jorge Aparicio · 2 shared papers, 2014–2026 · strength 0.32
  2. Carlos Escriva-Aranda · 1 shared paper, 2026 · strength 0.28
  3. Andrés Jesús Muñoz Martín · 1 shared paper, 2016 · strength 0.04
  4. Satvinder Mudan · 1 shared paper, 2016 · strength 0.04
  5. Justin Stebbing · 1 shared paper, 2016 · strength 0.04
  6. Demetris Papamichael · 1 shared paper, 2016 · strength 0.04
  7. Douglas J.A. Adamson · 1 shared paper, 2016 · strength 0.04
  8. Ray McDermott · 1 shared paper, 2016 · strength 0.04
  9. Angus George Dalgleish · 1 shared paper, 2016 · strength 0.04
  10. Roberto Pazo-Cid · 1 shared paper, 2016 · strength 0.04
  11. David Kuang-Fu Chang · 1 shared paper, 2016 · strength 0.04
  12. Alberto Zaniboni · 1 shared paper, 2016 · strength 0.04
  13. Joaquín Montalar · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.